IGF2BP2 and familial pancreatic carcinoma: Taken together, these results indicate that the promotion of cell proliferation ability by IGF2BP2 is reversed to certain extents by the re-expression of miR-141, which is consistent with our hypothesis that IGF2BP2-mediated PI3K-Akt activation promotes pancreatic cancer growth.